BMS

Brummer Multi-Strategy Portfolio holdings

AUM $24M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$24M
AUM Growth
+$7.48M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
14
New
Increased
Reduced
Closed

Top Buys

1
+$7.57M
2
+$6.6M
3
+$2M
4
ARVN icon
Arvinas
ARVN
+$1.47M
5
MRVI icon
Maravai LifeSciences
MRVI
+$1.02M

Top Sells

1
+$3.48M
2
+$3.25M
3
+$1.84M
4
BDX icon
Becton Dickinson
BDX
+$1M
5
SLNO
Soleno Therapeutics
SLNO
+$405K

Sector Composition

1 Real Estate 63.5%
2 Healthcare 35.99%
3 Materials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBRE icon
1
CBRE Group
CBRE
$37B
$6.75M 28.09%
+49,817
ADC icon
2
Agree Realty
ADC
$8.95B
$6.57M 27.34%
+87,127
ARVN icon
3
Arvinas
ARVN
$570M
$3.02M 12.58%
285,076
+118,734
ABVX
4
Abivax
ABVX
$10.3B
$2.5M 10.4%
22,428
+8,053
MRVI icon
5
Maravai LifeSciences
MRVI
$684M
$2.15M 8.95%
759,743
+302,036
WPC icon
6
W.P. Carey
WPC
$16.5B
$1.94M 8.07%
+28,508
ATAI icon
7
AtaiBeckley Inc
ATAI
$1.62B
$975K 4.06%
275,409
+40,494
GRML
8
Greenland Mines Ltd
GRML
$43.6M
$122K 0.51%
370,049
-236,708
BDX icon
9
Becton Dickinson
BDX
$40.9B
– –
-5,176
CI icon
10
Cigna
CI
$75.2B
– –
-11,818
FHTX icon
11
Foghorn Therapeutics
FHTX
$251M
– –
-4,708
IQV icon
12
IQVIA
IQV
$30.2B
– –
-8,183
NMRK icon
13
Newmark Group
NMRK
$2.53B
– –
-200,493
SLNO
14
DELISTED
Soleno Therapeutics
SLNO
– –
-8,741